Brain-Derived Glia Maturation Factor β Participates in Lung Injury Induced by Acute Cerebral Ischemia by Increasing

Fei-Fei Xu1, Zi-Bin Zhang1, Yang-Yang Wang1

  • 1Institute of Neurological Disease, Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610041, China.

Neuroscience Bulletin
|September 8, 2018
PubMed

Insights

Acute cerebral ischemia (ACI) up-regulates glia maturation factor beta (GMFB) in astrocytes. Brain-derived GMFB then damages lung endothelial cells, initiating lung injury after ACI.

Area of Science:

  • Neuroscience
  • Pulmonology
  • Cell Biology

Background:

  • Brain damage, specifically acute cerebral ischemia (ACI), is known to precipitate lung injury.
  • The precise molecular mechanisms linking ACI to lung damage remain incompletely understood.
  • Glia maturation factor beta (GMFB) emerged as a potential key mediator from proteomic analysis.

Purpose of the Study:

  • To investigate the role of glia maturation factor beta (GMFB) in the pathogenesis of lung injury following acute cerebral ischemia (ACI).
  • To elucidate the cellular source and mechanism by which ACI-induced GMFB affects pulmonary microvascular endothelial cells (PMVECs).

Main Methods:

  • Established a middle cerebral artery occlusion (MCAO) rat model to simulate ACI.
  • Utilized polymerase chain reaction, western blotting, and immunofluorescence to detect GMFB expression in astrocytes.
  • Employed oxygen-glucose deprivation (OGD) on primary astrocytes and RNA interference to modulate GMFB levels.
  • Assessed PMVEC viability and reactive oxygen species (ROS) production using conditioned medium from treated astrocytes and recombinant GMFB.

Main Results:

  • GMFB was significantly over-expressed in astrocytes within the brain following MCAO.
  • Primary astrocytes cultured under OGD conditions also showed increased GMFB levels.
  • Blocking GMFB in astrocytes improved the viability of co-cultured pulmonary microvascular endothelial cells (PMVECs).
  • Recombinant GMFB exposure to PMVECs increased ROS levels and impaired cell status.

Conclusions:

  • Glia maturation factor beta (GMFB) is demonstrably up-regulated in astrocytes subsequent to acute cerebral ischemia.
  • Brain-derived GMFB directly contributes to pulmonary microvascular endothelial cell (PMVEC) damage by elevating reactive oxygen species (ROS).
  • GMFB is identified as a potential initiating factor in ACI-induced lung injury.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
756
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.1K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
481
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
362
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
950